Evidence map›Paper›PMID 25290264›Full record

ArticleTranslational psychiatry2014

αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans.

A C Easton, A Lourdusamy, M Havranek, K Mizuno, J Solati, Y Golub, T-K Clarke, H Vallada, R Laranjeira, S Desrivières and 8 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Role of microRNAs in the pathophysiology of addiction.Wiley interdisciplinary reviews. RNA · 2021
    Pooled it
  2. Article
  3. Article
  4. CaNeuropharmacology · 2023
    Article
  5. A high-affinity cocaine binding site associated with the brain acid soluble protein 1.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Article
  7. Article
  8. The Role of CaMKII and ERK Signaling in Addiction.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Enhancing VTA CaMolecular psychiatry · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 5 countries.

A C EastonMRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, London, UK.
A Lourdusamy1] MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, London, UK [2] Faculty of Medicine and Health Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
M HavranekDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
K MizunoCentre for the Cellular Basis of Behavior, Institute of Psychiatry, King's College London, London, UK.
J Solati1] Department of Child and Adolescent Mental Health, University Clinic Erlangen, Erlangen, Germany [2] Department of Biology, Faculty of Science, Karaj Branch, Islamic Azad University, Karaj, Iran.
Y GolubDepartment of Child and Adolescent Mental Health, University Clinic Erlangen, Erlangen, Germany.
T-K ClarkeTranslational Research Laboratory, Department of Psychiatry, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
H ValladaDepartment and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.
R LaranjeiraUNIAD, Federal University of São Paulo, São Paulo, Brazil.
S DesrivièresMRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, London, UK.
G H MollDepartment of Child and Adolescent Mental Health, University Clinic Erlangen, Erlangen, Germany.
R MössnerDepartment of Psychiatry, University of Bonn, Bonn, Germany.
J KornhuberDepartment of Psychiatry and Psychotherapy, University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
G SchumannMRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, London, UK.
K P GieseCentre for the Cellular Basis of Behavior, Institute of Psychiatry, King's College London, London, UK.
C FernandesMRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, London, UK.
B B QuednowDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
C P Müller1] MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, London, UK [2] Department of Psychiatry and Psychotherapy, University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
King's College London · GBUniversitätsklinikum Erlangen · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Zurich · CHUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BRUniversity of Bonn · DEUniversity of Pennsylvania · US

Funding

Medical Research Council 93558Medical Research Council G0800393Medical Research Council G0901858
6 · The paper itself

Abstract

Although addiction develops in a considerable number of regular cocaine users, molecular risk factors for cocaine dependence are still unknown. It was proposed that establishing drug use and memory formation might share molecular and anatomical pathways. Alpha-Ca(2+)/calmodulin-dependent protein kinase-II (αCaMKII) is a key mediator of learning and memory also involved in drug-related plasticity. The autophosphorylation of αCaMKII was shown to accelerate learning. Thus, we investigated the role of αCaMKII autophosphorylation in the time course of establishing cocaine use-related behavior in mice. We found that αCaMKII autophosphorylation-deficient αCaMKII(T286A) mice show delayed establishment of conditioned place preference, but no changes in acute behavioral activation, sensitization or conditioned hyperlocomotion to cocaine (20 mg kg(-1), intraperitoneal). In vivo microdialysis revealed that αCaMKII(T286A) mice have blunted dopamine (DA) and blocked serotonin (5-HT) responses in the nucleus accumbens (NAcc) and prefrontal cortex after acute cocaine administration (20 mg kg(-1), intraperitoneal), whereas noradrenaline responses were preserved. Under cocaine, the attenuated DA and 5-HT activation in αCaMKII(T286A) mice was followed by impaired c-Fos activation in the NAcc. To translate the rodent findings to human conditions, several CAMK2A gene polymorphisms were tested regarding their risk for a fast establishment of cocaine dependence in two independent samples of regular cocaine users from Brazil (n=688) and Switzerland (n=141). A meta-analysis across both samples confirmed that CAMK2A rs3776823 TT-allele carriers display a faster transition to severe cocaine use than C-allele carriers. Together, these data suggest that αCaMKII controls the speed for the establishment of cocaine's reinforcing effects.

Indexed as

Reinforcement, PsychologyAdultAnimalsBehavior, AddictiveBehavior, AnimalCalcium-Calmodulin-Dependent Protein Kinase Type 2CocaineCocaine-Related DisordersFemaleHumansMaleMiceCalcium-Calmodulin-Dependent Protein Kinase Type 2Cocaine

Identifiers

PMID25290264
PMCPMC4350526
OpenAlexW2024638649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.